Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00524264 · ClinicalTrials.gov registry record · Phase 3
A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery
A Phase 3 study of Pain and Inflammation, sponsored by Allergan.
- Completed
- Registry status
- Phase 3
- Development phase
- 248
- Enrollment target
- 1
- Study location
NCT00524264: Completed Phase 3 study of Pain and Inflammation, sponsored by Allergan.
NCT00524264 is a Phase 3 study of Pain and Inflammation that has completed, run by Allergan. The registered enrollment target is 248 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (18% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00524264, a Phase 3 study of Pain and Inflammation, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 248 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a 16-day study to evaluate the safety and efficacy of ketorolac eye drops for the treatment of inflammation and pain associated with cataract surgery.
Primary Outcome
Anterior chamber inflammation is the sum of biomicroscopic cell and flare; each measured on a scale of 0-4 (Flare: 0 = no flare, 4 = intense flare / Cell: 0 = no cells, 4 = \>50 cells)
Conditions Studied
Interventions
- DRUG ketorolac
Study Locations (1)
California
- - Artesia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-04 |
| Phase | Phase 3 |
What the finished NCT00524264 record still lists
NCT00524264 is an interventional study that assigns participants to a tested intervention. The registered 248 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (18% lower).
The record links to 3 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which ketorolac is the first listed.
NCT00524264 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00524264 about?
NCT00524264 is a clinical study titled "A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery". This is a 16-day study to evaluate the safety and efficacy of ketorolac eye drops for the treatment of inflammation and pain associated with cataract surgery.
What is the current status of trial NCT00524264?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 248 participants. The study started on 2007-10. Estimated completion is 2008-04.
What conditions does trial NCT00524264 study?
This clinical trial studies the following conditions: Pain, Inflammation, Cataract Extraction.
What interventions are being tested in trial NCT00524264?
The interventions under investigation include: ketorolac (DRUG).
Who is sponsoring clinical trial NCT00524264?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00524264 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00524264's enrollment target sits among peer trials
248 73rd of 374 higher than 302 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
RECRUITING · Phase 3
-
Opioid-Free Orthopaedics
RECRUITING · Phase 3
-
Suzetrigine in Total Hip Arthroplasty
RECRUITING · Phase 3
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
RECRUITING · Phase 3
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04577911 · 248 participants
How is Social Connection Represented in the Brain?
- NCT04777994 · 248 participants · Phase 1
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- NCT04792489 · 248 participants · Phase 2
DALY II USA/ MB-CART2019.1 for DLBCL
- NCT04830137 · 248 participants · Phase 1
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia